Authors


Jordan Graff, MD, FACS

Latest:

Novel Intravitreal Injections: Faricimab and Aflibercept 8mg for the Treatment of Retinal Diseases

Panelists discuss how novel intravitreal agents faricimab and high-dose aflibercept 8mg offer potential advantages in treating retinal diseases through their extended durability and dual mechanism of action.


Zeba A. Syed

Latest:

Pearls for management of Pseudomonas scleritis

Dr Zeba A. Syed emphasises the importance of performing surgery sooner rather than later for patients with Pseudomonas scleritis


Dr Rajen U. Desai

Latest:

New goniotomy device + careful post-op care limits intraoperative bleeding

A new device for goniotomy has the advantage of an irrigation/aspiration system, which offers easier excision of the trabecular meshwork and better visibility. Dr Desai shares his experiences using the device as well as his tips and surgical pearls for success.


Dr Ramin Tadayoni

Latest:

Worldwide pathological myopia discussed by panel at EURETINA 2021

Dr Ramin Tadayoni discusses the myopia panel at the EURETINA 2021 virtual meeting.


Dr Maximilian K. Köppe
Dr Maximilian K. Köppe

Latest:

Artificial DMEK could help tackle endothelial donor tissue shortage

Newly developed acrylic implant provides option for patients with endothelial dysfunction.



Dr Marguerite B. McDonald

Latest:

New options are on the horizon for presbyopia-correcting drops

For ophthalmologists, finding the ideal solution for presbyopia has long been the ‘holy grail’ of the field.


Bela Parekh, BA, BS; Imane Tarib, MD; and Richard Awdeh, MD

Latest:

Harnessing digital media for enhanced patient engagement and outcomes

Patients who received digital education demonstrated a better understanding of their disease and its management


Dr Sara Giammaria

Latest:

Using pivotal study data to guide glaucoma patient management decisions

Two randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients.


Ms Faiza Bhombal

Latest:

Digital visual training helps treat disorders associated with close work

Computer software platform provides home vision exercises to overcome asthenopia.


Lynda Charters; Reviewed by Ursula Schmidt-Erfurth, MD

Latest:

Zooming in on geographic atrophy with OCT-based AI

New analysis brings disease progression and therapeutics into focus


By Lynda Charters; reviewed by Giovanni Montesano, MD

Latest:

Six-year findings from laser in glaucoma and ocular hypertension (LiGHT)

In visual field progression results, SLT was superior to ocular drops as first-line treatment for patients with glaucoma



Aude Couturier, MD, PhD

Latest:

Optimizing diagnosis and surgical management of diabetic retinopathy using advanced imaging technologies

Diabetic Retinopathy ranked as the fifth most common cause of blindness among adults aged 50 and older in 2020 according to data from the Global Burden of Disease study. Aude Couturier, MD shares her experience of using advanced imaging technologies to optimize diagnosis and surgical management of her DR patients in our latest Case of the Month.


Adam M. Katz, MD

Latest:

Letter to the Editor: Intravitreal injections. Who should perform them?

In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.


Prof. Dan Z. Reinstein, MD MA(Cantab) FRCSC FRCOphth DABO FEBO

Latest:

Back to the cornea – Treating hyperopic patients with Lenticule Extraction

Lenticule Extraction for treating patients with hyperopia is now available with SMILE® pro, performed on the VISUMAX® 800 from ZEISS. This additional option provides a valuable corneal-based alternative for younger patients without cataract. In this Case of the Month, you will discover the advantages of this procedure and review the outcomes of a 30-year-old patient who chose to undergo Lenticule Extraction with ZEISS SMILE pro after experiencing discomfort with contact lenses for many years.


Dr Claudia Priglinger

Latest:

First-ever retinal gene therapy: Does real-world experience back its use?

Recent reports of retinal atrophy have raised concerns on potential long-term safety.


Martin David Harp

Latest:

ARVO 2025: Ocular and systemic mitochondrial diseases may be key to dementia diagnosis

Detecting mitochondrial dysfunction may give clinicians a chance to reduce the rate of cognitive decline in patients with dementia





Dr Dagny Zhu

Latest:

Short-term corticosteroid use can provide rapid relief of allergy symptoms in dry eye disease

A short course of a low-dose corticosteroid eye drop can relieve inflammation with only a low increase in intraocular pressure.




Prof Paolo Vinciguerra

Latest:

Distorted corneas: How to regularise them with minimally invasive surgery

Sequential customised therapeutic keratectomy (SCTK) improves visual quality by eliminating superficial corneal high order aberrations


Ben Shaberman

Latest:

Gene therapy research ushers in new therapy options for retinal diseases

Foundation Fighting Blindness is a driving force in advancing retinal gene therapies into clinical trials.


Professor Winifred Amoaku

Latest:

Risks and management of diabetic retinopathy in paediatric patients

Diabetes mellitus, which is a common chronic disease in children, can lead to significant eye morbidities with long-lasting effects, including diabetic retinopathy. Treatment should be tailored to the individual patient.


Dr Panayiota Founti

Latest:

The impact of landmark studies on clinical practice in glaucoma

Landmark randomised controlled trials have advanced the understanding and treatment of glaucoma.


Dr Paulina Ocieczek

Latest:

Landscape of genetic therapies for USH2A-related retinitis pigmentosa

Increasing understanding of the genetics behind Usher syndrome suggests that treatment may become possible in the very near future.


Dr Livia Faes

Latest:

Assessing barriers to retinal care during a pandemic

A global survey of retinal experts assessed their perceptions of evolving clinical practice in the Covid-19 era, focusing on digital teleophthalmology, home monitoring and decentralised patient care.

© 2025 MJH Life Sciences

All rights reserved.